Syros Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Watertown MA United States (2012)

Organization Overview

First Clinical Trial
2016
NCT02807558
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Syros Pharmaceuticals